ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,250Medicare Part D Prescriptions Filled, Including Refills

Rank: 24 out of 1383

$1.33M Total Retail Price of All Prescriptions

Rank: 20 out of 1383

703 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 703 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

27% of this provider’s 703 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 26,074 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
HYDROCODONE-ACETAMINOPHEN 1,020 968 S3 1 1
LEVOTHYROXINE SODIUM 891 870 2 4
FUROSEMIDE 632 619 3 7
MIRTAZAPINE 626 614 4 51
AMLODIPINE BESYLATE 541 531 5 6
SIMVASTATIN 539 485 6 2
CITALOPRAM HBR 531 496 7 15
QUETIAPINE FUMARATE 511 510 8 70
POTASSIUM CHLORIDE 492 477 9 12
OMEPRAZOLE 464 459 10 5
PAROXETINE HCL 460 443 11 55
JANTOVEN 453 453 12 146
BUMETANIDE 443 443 13 122
METOPROLOL TARTRATE 436 404 14 9
GABAPENTIN 421 403 15 11
CARVEDILOL 414 411 16 24
POLYETHYLENE GLYCOL 3350 375 372 17 64
NAMENDA 367 367 18 49
METFORMIN HCL 361 331 19 8
ZOLPIDEM TARTRATE 360 333 20 17
DONEPEZIL HCL 341 341 21 35
LEVEMIR 324 323 22 145
PANTOPRAZOLE SODIUM 281 281 23 32
SPIRONOLACTONE 271 271 24 67
CLOPIDOGREL 266 255 25 28
NEXIUM 255 229 26 26
TRAZODONE HCL 244 241 27 36
LISINOPRIL 241 233 28 3
GLIMEPIRIDE 231 227 29 31
PLAVIX 229 225 30 43
SERTRALINE HCL 219 217 31 21
PREDNISONE 215 186 32 40
CLONIDINE HCL 204 182 33 44
SEROQUEL 199 192 34 130
CYMBALTA 197 189 35 53
ATORVASTATIN CALCIUM 188 169 36 18
MELOXICAM 185 166 37 20
FENTANYL 180 174 S2 38 92
ALBUTEROL SULFATE 179 179 39 124
OXYCODONE-ACETAMINOPHEN 178 138 S2 40 107
TAMSULOSIN HCL 172 166 41 30
DIVALPROEX SODIUM 169 164 42 78
NOVOLIN R 164 164 43 167
ADVAIR DISKUS 163 163 44 63
IPRATROPIUM BROMIDE 161 161 45 174
CARBIDOPA-LEVODOPA 157 157 46 108
LANTUS 157 155 46 50
RANITIDINE HCL 152 145 48 19
PROMETHAZINE HCL 152 141 R 48 56
HYDRALAZINE HCL 147 147 50 86
ISOSORBIDE MONONITRATE ER 146 146 51 66
KLOR-CON M20 145 137 52 100
ENABLEX 140 140 53 253
ATENOLOL 138 131 54 16
SPIRIVA 136 133 55 45
ESCITALOPRAM OXALATE 131 131 56 99
LOSARTAN POTASSIUM 130 130 57 23
PRAVASTATIN SODIUM 128 124 58 14
BENAZEPRIL HCL 128 122 58 38
OXYCODONE HCL-ACETAMINOPHEN 126 124 S2 60 81
ALLOPURINOL 122 101 61 33
HUMULIN R 117 117 62 215
DOXYCYCLINE HYCLATE 115 94 63 94
RISPERIDONE 114 114 64 71
HYDROCHLOROTHIAZIDE 113 89 65 10
ALENDRONATE SODIUM 113 113 65 37
ENALAPRIL MALEATE 112 112 67 75
FLUOXETINE HCL 111 108 68 52
CEFUROXIME 110 100 69 164
FAMOTIDINE 107 94 70 61
AGGRENOX 106 106 71 191
OLANZAPINE 102 102 72 164
LEVOFLOXACIN 102 101 72 88
PHENYTOIN SODIUM EXTENDED 102 102 72 137
TOBRAMYCIN-DEXAMETHASONE 100 99 75 384
CIPROFLOXACIN HCL 99 92 76 54
DILTIAZEM 24HR ER 96 96 77 161
TRIAMCINOLONE ACETONIDE 94 78 78 159
METOPROLOL SUCCINATE 90 90 79 29
PRAMIPEXOLE DIHYDROCHLORIDE 89 86 80 160
LYRICA 89 89 80 72
LEVETIRACETAM 87 86 82 134
AMIODARONE HCL 87 87 82 188
FLUTICASONE PROPIONATE 86 84 84 39
CEPHALEXIN 83 80 85 87
DIGOXIN 79 79 86 59
IPRATROPIUM-ALBUTEROL 77 77 87 138
ROPINIROLE HCL 76 76 88 79
DIOVAN 76 76 88 58
LEXAPRO 74 74 90 241
CEFDINIR 74 74 90 171
NYSTATIN 74 70 90 132
EVISTA 71 71 93 152
LAMOTRIGINE 71 71 93 210
TERAZOSIN HCL 70 70 95 111
CEFTRIAXONE 70 67 95 175
TRAMADOL HCL 70 68 95 25
EXELON 67 67 98 117
LIDOCAINE HCL 67 65 98 219
NOVOLOG 67 67 98 139
LEVOTHROID 65 59 101 355
SINGULAIR 63 63 102 82
NITROFURANTOIN MONO-MACRO 63 63 102 193
PRIMIDONE 62 62 104 207
BUSPIRONE HCL 61 61 105 109
LIDODERM 59 57 106 228
FLUVOXAMINE MALEATE 59 59 106 303
CARAFATE 58 44 108 370
ONDANSETRON HCL 58 58 108 212
SULFAMETHOXAZOLE-TRIMETHOPRIM 56 54 110 89
NITROGLYCERIN PATCH 56 56 110 177
COMBIVENT 56 42 110 116
LISINOPRIL-HYDROCHLOROTHIAZIDE 55 40 113 27
ISOSORBIDE DINITRATE 54 54 114 216
FLUCONAZOLE 53 44 115 136
OXYCODONE HCL 53 41 S2 115 62
ACARBOSE 52 52 117 345
METOCLOPRAMIDE HCL 52 45 117 127
GLYBURIDE 52 47 R 117 46
RANEXA 51 51 120 321
VESICARE 50 42 121 182
ABILIFY 50 50 121 178
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 11, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.